Involvement of cortical neurotensin in the regulation of rat meso- cortico-limbic dopamine neurons: Evidence from changes in the number of spontaneously active A10 cells after neurotensin receptor blockade

Synapse

Volumn 26, Issue 4, 1997, Pages 370-380

  Santucci, Vincent ^a   Gueudet, Christiane ^a   Steinberg, Régis ^a   Le Fur, Gérard ^a   Soubrié, Philippe ^a  

^a SANOFI   (France)

Author keywords

Midbrain dopamine neurons; Neurotensin receptors; Number of spontaneously active cells; Prefrontal cortex; SR 48692

Indexed keywords

2 [[1 (7 CHLORO 4 QUINOLINYL) 5 (2,6 DIMETHOXYPHENYL) 3 PYRAZOLYL]CARBONYLAMINO] 2 ADAMANTANECARBOXYLIC ACID; APOMORPHINE; HALOPERIDOL; NEUROTENSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DRUG RECEPTOR BINDING; ELECTROPHYSIOLOGY; MESENCEPHALON; NERVE FUNCTION; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; VENTRAL TEGMENTUM;

ANIMALS; CELL COUNT; CEREBRAL CORTEX; DOPAMINE; LIMBIC SYSTEM; MALE; MEMBRANE POTENTIALS; MICRODIALYSIS; NEURONS; NEUROTENSIN; PYRAZOLES; QUINOLINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROTENSIN;

EID: 0030747714     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(199708)26:4<370::AID-SYN5>3.0.CO;2-3     Document Type: Article

References (43)

1. Audinat, E., Hermel, J.M., and Crepel, F. (1989) Neurotensin-induced excitation of neurons of the rat's frontal cortex studied intracellularly in vitro. Exp. Brain. Res., 78:358-368.
2. Azzi, M., Gully, D., Heaulme, M., Bérod, A., Pélaprat, D., Kitabgi, P., Boigegrain, R., Maffrand, J.-P., Le Fur, G., and Rostène, W. (1994) Neurotensin receptor interaction with dopaminergic systems in the guinea-pig brain shown by neurotensin receptor antagonists. Eur. J. Pharmacol., 255:167-174.
3. Beauregard, M., Ferron, A., and Descarries, L. (1992) Opposite effects of neurotensin on dopamine inhibition in different regions of the rat brain: An iontophoretic study. Neuroscience, 47:613-619.
4. Blaha, C.D., and Phillips, A.G. (1992) Pharmacological evidence for common mechanisms underlying the effects of neurotensin and neuroleptics on in vivo dopamine efflux in the rat nucleus accumbens. Neuroscience, 49:867-877.
5. Brun, P., Steinberg, R., Le Fur, G., and Soubrié, P. (1995) Blockade of neurotensin raptor by SR 48692 potentiates the facilitatory effect of haloperidol on the evoked in vivo dopamine release in the rat nucleus accumbens. J. Neurochem., 64:2073-2079.
6. Bunney, B.S., and Grace, A.A. (1978) Acute and chronic haloperidol treatment : comparison of effects on nigral dopaminergic cell activity. Life Sci., 23:1715-1728.
7. Bunney, B.S., Chiodo, L.A., and Grace, A.A. (1991) Midbrain dopamine system electrophysiological functioning: A review and new hypothesis. Synapse, 9:79-94.
8. Ervin, G.N., Birkemo, L.S., Nemeroff, C.B., and Prange, A.J. Jr. (1981) Neurotensin blocks certain amphetamine-induced behaviors. Nature, 291:73-76.
9. Gonon, F.G. (1988) Nonlinear relationship between impulse flow and dopamine released by rat midbrain dopaminergic neurons as studied by in vivo electrochemistry. Neuroscience, 24:19-28.
10. Grace, A.A. (1992) The depolarization block hypothesis of neuroleptic action: Implications for the etiology and treatment of schizophrenia. J. Neural Transm., 36:91-131.
11. Grace, A.A., and Bunney, B.S. (1984) The control of firing pattern in nigral dopamine neurons: Burst firing. J. Neurosci., 4:2877-2890.
12. 9 dopamine neuronal activity in the rat. NeuroReport, 6:1293-1297.
13. Gully, D., Canton, M., Boigegrain, R., Jeanjean, F., Molimard, J.-C., Poncelet, M., Gueudet, C., Heaulme, M., Leyris, R., Brouard, A., Pelaprat, D., Labbé-Jullié, C., Mazella, J., Soubrié, P., Maffrand, J.-P., Rostène, W., Kitabgi, P., and Le Fur, G. (1993) Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor. Proc. Natl. Acad. Sci. U.S.A., 90:65-69.
14. 125I-labeled neurotensin binding site density in corticolimbic structures of the rat brain. Proc. Natl. Acad. Sci. U.S.A., 83:6203-6207.
15. Hollerman, J.R., Abercrombie, E.D., and Grace, A.A. (1992) Electrophysiological, biochemical, and behavioral studies of acute haloperidol-induced depolarization block of nigral dopamine neurons. Neuroscience, 47:589-601.
16. Jolas, T., and Aghajanian, G.K. (1996) Neurotensin excitation of serotonergic neurons in the dorsal raphe nucleus of the rat in vitro. Eur. J. Neurosci., 8:153-161.
17. Jolicoeur, F.B., De Michele, G., and Barbeau, A. (1983) Neurotensin affects hyperactivity but not stereotypy induced by pre-and postsynaptic dopaminergic stimulation. Neurosci. Biobehav. Rev., 7:385-390.
18. Kalivas, P.W. (1993) Neurotransmitter regulation of dopamine neurons in the ventral tegmental area. Brain Res. Rev., 18:75-113.
19. Kalivas, P.W., Nemeroff, C.B., and Prange, A.J. Jr. (1984) Neurotensin microinjection into the nucleus accumbens antagonizes dopamine-induced increase in locomotion and rearing. Neuroscience, 11:919-930.
20. Karreman, M., and Moghaddam, B. (1996) The prefrontal cortex regulates the basal release of dopamine in the limbic striatum: An effect mediated by ventral tegmental area. J. Neurochem., 66:589-598.
21. McCarthy, P.S., Walker, R.J., Yajima, H., Kitagawa, K., and Woodruff, G.N. (1979) The action of neurotensin on neurons in the nucleus accumbens and cerebellum of the rat. Gen. Pharmacol., 10:331-333.
22. Minabe, Y., Emori, K., Toor, A., Stutzmann, G.E., and Ashby, C.R. Jr (1996) The effect of the acute and chronic administration of CP 96,345, a selective neurokinin1 receptor antagonist, on midbrain dopamine neurons in the rat: A single unit, extracellular recording study. Synapse, 22:35-45.
23. Murase, S., Grenhoff, J., Chouvet, G., Gonon, F.G., and Svensson, T.H. (1993) Prefrontal cortex regulates burst firing and transmitter release in rat mesolimbic dopamine neurons studied in vivo. Neurosci. Lett., 157:53-56.
24. Paxinos, G., and Watson, C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, Sydney.
25. Pinnock, R.D. (1985) Neurotensin depolarizes substantia nigra dopamine neurons. Brain Res., 338:141-154.
26. Poncelet, M., Santucci, V., Paul, R., Gueudet, C., Lavastre, S., Guitard, J., Steinberg, R., Terranova, J.-P., Brelière, J.-C., Soubrié, P., and Le Fur, G. (1993) Neuropharmacological profile of a novel and selective ligand of the sigma site. Neuropharmacology, 32:605-615.
27. Poncelet, M., Gueudet, C., Soubrié, P., and Le Fur, G. (1994a) Turning behavior induced by intrastriatal injection of neurotensin in mice: sensitivity to non-peptide neurotensin antagonists. Naunyn Schmiedeberg's Arch. Pharmacol., 39:57-60.
28. Poncelet, M., Souilhac, J., Gueudet, C., Terranova, J.-P., Gully, D., Le Fur, G., and Soubrié, P. (1994b) Effects of SR 48692, a selective non-peptide neurotensin receptor antagonist, on two dopamine-dependent behavioral responses in mice and rats. Psychopharmacology, 116:237-241.
29. Quirion, R. (1983) Interactions between neurotensin and dopamine in the brain. Peptides, 4:609-615.
30. Rivest, R., Jolicoeur, F.B., and Marsden, C.A. (1991) Neurotensin causes a greater increase in the metabolism of dopamine in the accumbens than in the striatum in vivo. Neuropharmacology, 30:25-33.
31. Sesack, S.R., and Pickel, V.M. (1992) Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area. J. Comp. Neurol., 320:145-160.
32. Seutin, V., Massotte, L., and Dresse, A. (1989) Electrophysiological effects of neurotensin on dopaminergic neurons of the ventral tegmental area of the rat in vitro. Neuropharmacology, 28:949-954.
33. Shi, W.-X., and Bunney, B.S. (1992) Actions of neurotensin: A review of the electrophysiological studies. Ann. N.Y. Acad. Sci., 668:129-145.
34. Steinberg, R., Brun, P., Fournier, M., Souilhac, J., Rodier, D., Mons, G., Terranova, J.-.P, Le Fur, G., and Soubrié, P. (1994) SR 48692, a non-peptide neurotensin receptor antagonist differentially affects neurotensin-induced behavior and changes in dopaminergic transmission. Neuroscience, 59:921-929.
35. Steinberg, R., Rodler, D., Mons, G., Gully, D., Le Fur, G., and Soubrié, P. (1995) SR 48692-sensitive neurotensin receptors modulate acetylcholine release in the rat striatum. Neuropeptides, 29:27-31.
36. Studler, J.M., Kitabgi, P., Tramu, G., Hervé, D., Glowinski, J., and Tassin, J.P. (1988) Extensive co-localization of neurotensin with dopamine in rat meso-cortico-frontal dopaminergic neurons. Neuropeptides, 11:95-100.
37. Suaud-Chagny, M.F., Chergui, K., Chouvet, G., and Gonon, F. (1992) Relationship between dopamine release in the rat nucleus accumbens and the discharge activity of dopaminergic neurons during local in vivo application of amino acids in the ventral tegmental area. Neuroscience, 49:63-72.
38. Tanganelli, S., O'Connor, W.T., Ferraro, L., Bianchi, C., Beani, L., Ungerstedt, U., and Fuxe, K. (1994) Facilitation of GABA release by neurotensin is associated with a reduction of dopamine release in rat nucleus accumbens. Neuroscience, 60:649-657.
39. Thierry, A.M., Chevalier, G., Ferron, A., and Glowinski, J. (1983) Diencephalic and mesencephalic efferents of the medial prefrontal cortex in the rat: Electrophysiological evidence for the existence of branched axons. Exp. Brain Res., 50:275-282.
40. Tong, Z.-Y., Overton, P.G., and Clark, D. (1996) Stimulation of the prefrontal cortex in the rat induces patterns of activity in midbrain dopaminergic neurons which resemble natural burst events. Synapse, 22:195-208.
41. Wachtel, S.R., and White, F.J. (1988) Electrophysiological effects of BMY 14802, a new potential antipsychotic drug, on midbrain dopamine neurons in the rat: Acute and chronic studies. J. Pharmacol. Exp. Ther., 244:410-416.
42. Wagstaff, J.D., Bush, L.G., Gibb, J.W., and Hanson, G.R. (1994) Endogenous neurotensin antagonizes methamphetamine-enhanced dopaminergic activity. Brain Res., 665:237-244.
43. White, F.J., and Wang, R.Y. (1983) Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons. Science, 221:1054-1057.